<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41">
 <label>41</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wilkie</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Van Schalkwyk</surname>
    <given-names>MCI</given-names>
   </name>
   <name>
    <surname>Hobbs</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Davies</surname>
    <given-names>DM</given-names>
   </name>
   <name>
    <surname>van der Stegen</surname>
    <given-names>SJ</given-names>
   </name>
   <name>
    <surname>Parente Pereira</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling</article-title>. 
  <source>J Clin Immunol</source> (
  <year>2012</year>) 
  <volume>32</volume>(
  <issue>5</issue>):
  <page-range>1059–70</page-range>.  
  <pub-id pub-id-type="doi">10.1007/s10875-012-9689-9</pub-id>
 </mixed-citation>
</ref>
